导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -14.51% | 4076/4773 |
| 近一周 | -2.17% | 1379/5462 |
| 近一月 | -0.74% | 822/5421 |
| 近一季 | -8.83% | 2980/5209 |
| 近半年 | -16.96% | 4138/4920 |
| 近一年 | -6.61% | 3190/4366 |
| 近两年 | 28.47% | 2337/2954 |
| 近三年 | 6.54% | 1810/2253 |
| 成立以来 | 46.89% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.54% 3860/4961 |
0.51% 3170/5312 |
- - |
- - |
| 2025 | 18.59% 2300/4813 |
-5.26% 3273/3635 |
10.98% 224/4076 |
6.93% 3490/4524 |
5.48% 438/4813 |
| 2024 | 13.14% 1172/3463 |
-3.00% 1462/2808 |
-1.28% 1020/3014 |
13.09% 2248/3129 |
4.47% 704/3463 |
| 2023 | -12.56% 1488/2656 |
0.78% 1698/2280 |
2.41% 146/2385 |
-10.41% 1994/2515 |
-5.44% 1357/2655 |
| 2022 | -24.80% 1260/2207 |
-21.42% 1625/1919 |
3.67% 1113/2016 |
-7.42% 125/2113 |
-0.29% 1588/2208 |
| 2021 | 21.25% 164/1822 |
-15.03% 1185/1255 |
11.13% 399/1330 |
11.60% 109/1466 |
15.06% 66/1822 |
| 2020 | 63.23% 109/1250 |
-1.85% 244/1028 |
12.34% 691/1067 |
28.39% 16/1164 |
15.30% 221/1184 |
| 2019 | 35.91% 364/1092 |
34.58% 109/754 |
-8.58% 599/804 |
8.46% 63/850 |
1.84% 872/918 |
| 2018 | -25.91% 367/834 |
- - |
- - |
- - |
-13.46% 535/691 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 国泰国证航天军工指数(LOF)A VS. 长安沪深300非周期A(740101) |